Dr. James C. Yao on Everolimus in Pancreatic Neuroendocrine Tumors
13 vistas
• 07/13/23
0
0
Empotrar
administrator
Suscriptores
James C. Yao, MD, discusses the administration of everolimus (Afinitor) for patients with pancreatic neuroendocrine tumors
For more resources and information regarding targeted therapies in cancer: http://targetedhc.com/
Mostrar más
Comentarios de Facebook
SORT BY-
Top Comentarios
-
Últimos comentarios